Invention Grant
- Patent Title: Anti-CS1 antibodies and antibody drug conjugates
-
Application No.: US14928738Application Date: 2015-10-30
-
Publication No.: US10011657B2Publication Date: 2018-07-03
- Inventor: Kurt C. Gish , Han K. Kim , Louie Naumovski
- Applicant: AbbVie Biotherapeutics Inc.
- Applicant Address: US CA Redwood City
- Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Dechert LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; A61K45/06 ; A61K47/48
Abstract:
The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
Public/Granted literature
- US20160122430A1 ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Public/Granted day:2016-05-05
Information query
